We build great technology companies
NL-3721 AK Bilthoven
Send an email
If your company has already paying customers, we expect the following key items to be addressed in the business plan.
|Customer Problem: who has the problem and how you will solve it?||Market: how big is the market and what is the competitive landscape?|
|Product and/or service: what is the status and differentation of technology solution?||Business model: what is the monetization strategy and what is your 3 years financial forecast?|
|Finance: how much capital is needed and how the proceeds will be used?||Team: what is the background and qualifications?|
We will give you a clear view of the main obstacles for growing your business based on only 4 questions:
In case your answers on the first two questions have a score of 100%, your company is meeting its monthly targets the last 18-months consecutive and finaly your company is able to grow three times faster with the current cash flow, we are not able to add much value.
In all other cases, there needs to be work done on your strategy (question 1), on your team (question 2) on your execution (question 3). In those cases, there is also an additional capital need.
Please click for a personal discussion with one of the partners of Value Creation Capital.
In addition, Value Creation Capital and Spark Entrepreneurs Education offer jointly an acceleration program of 12 months. Ambitious tech companies (scale-ups) are supported hands-on in reaching their growth targets. Click for more information on the Program.
Amsterdam, NL – Dispertech B.V., a deeptech startup in the field of nanoparticle analysis instruments and solutions, has received an investment from a consortium of investors led by Value Creation Capital.
Dispertech’s products enable researchers in the field of life science and healthcare to measure size, refractive index, and concentration of biological nanoparticles, including extracellular vesicles, viruses, lipid-nanoparticles, nanomedicine and RNA-vaccines. Biological nanoparticles is an important and fast growing field of research with high potential in both diagnostic and therapeutic applications.
The investment will enable Dispertech to accelerate its sales effort, scale up its organisation, and strengthen its leading position in the scientific market. Furthermore, the investment allows Dispertech to implement an ambitious innovation program for the development of nanoparticle analysis technology for the next generation of products.
Hans Brouwer, CEO of Dispertech comments: “We are thrilled to receive the trust of Value Creation Capital. Their investment and venture support will enable us to realise our growth ambitions.”
Willem van den Berg, Managing Partner of Value Creation Capital comments: “We are excited to invest in this interesting Deep Tech nanoparticle detection domain and enabling further growth of Dispertech.”